PHARMA MANUFACTURING
ActivePHARMA MANUFACTURING has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €2.75M and a net result of €2k. Equity is growing by ~4.1% per year across the filed fiscal years. Its solvency ranks better than 95% of 862 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2024
73
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability61▼-1
Solvency100=
Growth43=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200k at 30 days acceptable
Liquidity ample (current ratio 10.35 against 9.65 in 2023; short-term debt: 8.4% and cash: 1.3% of total assets), and 8.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Sector 10
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
91.6%
Return on assets
0.1%
Age of the figures
20 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
74 d late
2022
113 d late
2021
78 d late
2020
60 d late
2019
140 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, full schema
Turnover
€2.79M▼ 4.4%
2023 · €2.91M
2019: €0
2020: €3.16M
2021: €2.84M
2022: €2.92M
2023: €2.91M
2019 → 2024
EBIT margin
0.2%▼ 0.5pp
2023 · 0.7%
2020: 9.5%
2021: -5.7%
2022: 13.4%
2023: 0.7%
2020 → 2024
Net result
€2k▼ 83.5%
2023 · €14k
2018: €153k
2019: €248k
2020: €227k
2021: €-163k
2022: €338k
2023: €14k
2018 → 2024
Working capital
€2.36M▲ 7.3%
2023 · €2.20M
2018: €1.43M
2019: €1.67M
2020: €1.90M
2021: €1.84M
2022: €2.14M
2023: €2.20M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Turnover€3.16M-€2.84M▼ 10.2%€2.92M▲ 2.8%€2.91M▼ 0.2%€2.79M▼ 4.4%
Equity€2.56M-€2.40M▼ 6.4%€2.74M▲ 14.1%€2.75M▲ 0.5%€2.75M▲ 0.1%
Operating result€300k-€-162k€391k€21k▼ 94.5%€7k▼ 68.2%
Net result€227k-€-163k€338k€14k▼ 95.8%€2k▼ 83.5%
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 68% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €3.01M
Fixed assets
€394k▼ 28.7%
Current assets
€2.61M▲ 6.5%
Equity and liabilities €3.01M
Equity
€2.75M▲ 0.1%
Debt
€252k▼ 0.8%
The debt ratio falls from 8.5% to 8.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€178k▼
2023 · €193k
Cash flow
€173k▼
2023 · €186k
Solvency
91.6%▲
2023 · 91.5%
Current ratio
10.35▲
2023 · 9.65
Quick ratio
6.41▲
2023 · 6.16
Debt / equity
0.09▼
2023 · 0.09
ROE
0.1%▼
2023 · 0.5%
ROA
0.1%▼
2023 · 0.5%
Interest coverage
766.10▲
2023 · 508.24
Debt
€252k▼
2023 · €254k
Debt ≤ 1 year
€252k▼
2023 · €254k
Income taxes
€5k▼
2023 · €7k
Staff costs
€506k▲
2023 · €485k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€3.01M€3.01M=
Fixed assets21/28€553k€394k▼
Intangible fixed assets21€7k€3k▼
Tangible fixed assets22/27€546k€391k▼
Land and buildings22€285k€204k▼
Plant, machinery and equipment23€113k€77k▼
Furniture and vehicles24€148k€109k▼
Current assets29/58€2.45M€2.61M▲
Stocks and contracts in progress3€888k€996k▲
Stocks30/36€888k€996k▲
Amounts receivable within one year40/41€1.50M€1.55M▲
Trade receivables40€501k€414k▼
Other amounts receivable41€1,000k€1.14M▲
Cash at bank and in hand54/58€55k€38k▼
Deferred charges and accrued income490/1€10k€27k▲
Equity and liabilities
Total equity and liabilities10/49€3.01M€3.01M=
Equity10/15€2.75M€2.75M▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€1.76M€1.76M=
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€1.75M€1.75M=
Profit (loss) carried forward14€934k€936k▲
Investment grants15€349€314▼
Amounts payable17/49€254k€252k▼
Amounts payable within one year42/48€254k€252k▼
Trade debts44€131k€159k▲
Suppliers440/4€131k€159k▲
Taxes, remuneration and social security45€124k€93k▼
Taxes450/3€39k€36k▼
Remuneration and social security454/9€84k€57k▼
Other amounts payable47/48€0€116▲
Accrued charges and deferred income492/3€0€0=
Income statement
Code20232024
Turnover70€2.91M€2.79M▼
Goods, raw materials, services and sundry goods60/61€2.19M€2.11M▼
Remuneration, social security and pensions62€485k€506k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€172k€171k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€47k€2k▼
Other operating charges640/8€20k€21k▲
Non-recurring operating charges66A€550-
Gross operating margin9900€746k€707k▼
Operating profit (loss)9901€21k€7k▼
Financial income75/76B€63€701▲
Recurring financial income75€63€701▲
Financial charges65/66B€380€232▼
Recurring financial charges65€380€232▼
Profit (loss) for the period before taxes9903€21k€7k▼
Income taxes67/77€7k€5k▼
Profit (loss) for the period9904€14k€2k▼
Profit (loss) for the period to be appropriated9905€14k€2k▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.03M€936k▼
Profit (loss) brought forward from the previous period14P€1.02M€934k▼
Transfer to equity691/2€100k-
To other reserves6921€100k-
Social balance
Average headcount (FTE)90879.29.6▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 61 days late
2024
13-10
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 74 days late
2023
21-11
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 113 days late
2022
31-12
Financial
Back to profitnet €338k
Net result €338k after one loss-making year.
17-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 78 days late
2021
31-12
Financial
Weakest financial yearnet €-163k ▼172%
Net result drops to €-163k, the lowest in the series; recovery starts the following year.
29-09
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 60 days late
2020
18-12
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 140 days late
2019
03-12
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 125 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
2017
22-11
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 114 days late
2016
31-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gembloux · 1 establishment unit since 2001
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Guillaume Fouquet,Isnes 165032 GemblouxGround area
9,962 m²
Building footprint
1,817 m²
Volume, LiDAR
13,614 m³
Parcel 92065B0063/00G003, Wallonia · tallest building 8.7 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Rue Guillaume Fouquet,Isnes 16, 5032 Gembloux
since 20012.098.387.538
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92065B0063/00G003 | Wallonia | 9,962 m² | 1 · 1,817 m² | 8.7 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteGembloux2.098.387.538
Similar companies · same sector, comparable size
Be-Life
BE 0444.733.518
Gembloux · Eq €3.40M
SUPPLEMENTS DISTRIBUTION
BE 0464.396.606
Aubange · Eq €2.22M
Nutrimed
BE 0821.193.684
Dendermonde · Eq €3.62M
MEDIX Laboratoires
BE 0543.388.753
Oudenaarde · Eq €4.16M
METAROM BENELUX
BE 0405.669.044
Vorst · Eq €4.77M
Of 87 companies in sector 10860 we hold annual accounts for 47. 18 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded16-07-2001
Fiscal year end31-12
Activities, NACEBEL
10860Manufacture of food products
82920Office administrative, office support and other business support activities
46389Wholesale of other food products
51384
Sources
Crossroads Bank for EnterprisesNational Bank · 23 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
3 entriesE-mail:pharma.manufacturing@skynet.be
Phone:081/73.55.81
Fax:081/73.55.61